A depiction of two hydrogen molecules. Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Clean energy developer Hazer Group Ltd (ASX:HZR) has raised approximately $5.4M through a share purchase plan (SPP) to push towards its goal of scaling up production of hydrogen and graphite from the company’s commercial demonstration plant (CDP) in Western Australia.

The SPP – which ended on March 15 – had been set with a target of $4 million, but achieved well beyond that, with Hazer raising $5,393,000 before costs.

Overall, this involved applications for 10,786,000 new shares and 2,696,500 options.

Hazer had already boosted its coffers with a share placement last month which had raised $9 million, with shares being issued at $0.50 each.

The stock has been hotly-watched for years and its CDP has been hit with operational delays in the past, including faulty parts which required replacement.

CEO and managing director, Glenn Corrie said the successful fundraising would enable the company to focus on its production and development targets for the year.

“With the successful completion of our Placement and SPP, we can now move forward this year with a robust balance sheet focussed on delivering our CDP test program and commercialisation strategy,” he said.

“Hazer’s technology is now successfully proven in continuous operation at commercial demonstration scale and with interest multiplying, we are eager to provide potential customers with a low-cost hydrogen and decarbonisation solution that is available for deployment today.”

Founded in 2010, Hazer has been developing a carbon-negative process to convert natural gas and other feedstocks into hydrogen and graphite.

First production from its CDP in Perth was announced in January.

Hazer Group shares are trading at 50c.

HZR by the numbers
More From The Market Online
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Dale Gillham’s weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in th…
Image of eyes in closeup

Scientific conference spotlights PYC’s work on blindness disease treatment

PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat…
Image of four gold necklaces

Sales growth pushes Lovisa’s fortunes (and shares) upwards

Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and…
Organised crime concept

Panic, paranoia, and gangland politics: HotCopper users react to Dubber’s missing $26M

HotCopper users have reacted to overnight reports Dubber has seen $26M disappear from its coffers due…